VTRS CIK: 1792044

Viatris Inc

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
10.9
FY22:
10.6
FY23:
13.0
FY24:
9.52
FY25:
9.79
(positive)
Change from FY21 to FY25
billions USD
FY21:
43.9
FY22:
39.4
FY23:
34.7
FY24:
32.0
FY25:
27.4
Total assets
Change from FY21 to FY25
billions USD
FY21:
54.8
FY22:
50.0
FY23:
47.7
FY24:
41.5
FY25:
37.2

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
9.88
FY22:
6.75
FY23:
7.78
FY24:
5.78
FY25:
7.09
(negative)
Change from FY21 to FY25
billions USD
FY21:
24.5
FY22:
22.2
FY23:
19.4
FY24:
17.1
FY25:
15.4
(positive)
Change from FY21 to FY25
billions USD
FY21:
20.5
FY22:
21.1
FY23:
20.5
FY24:
18.6
FY25:
14.7
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
54.8
FY22:
50.0
FY23:
47.7
FY24:
41.5
FY25:
37.2

All amounts in billions USD Data source:SEC EDGAR